Trump backer busted in Aussie biotech bungle

Outsider

10 August 2018
| By Outsider |
image
image
expand image

It would seem that when you’re a US Congressman, sitting down with your son to have “the drug talk” can mean something entirely different to what takes place over a suburban kitchen table.

Instead of the usual speeches of “don’t drink and drive” or “there’s a time and place for doing everything … and it’s called university,” Rep. Christopher Collins of New York allegedly told his son something more along the lines of: “The drug-trial results from this Aussie biotech mob, upon whose board I sit by the way, came back negative. Wanna dump 1.4 million shares?”

According to reports, Collins was arrested on federal charges relating to securities fraud last week in a case involving Australian biotech Innate Immunotherapeutics (try saying that three times, really quickly, under water, with a mouth full of marbles.)

A Securities and Exchange Commission complaint against Collins — the first congressional Republican to endorse Trump’s bid for the White House — also details charges against his son Cameron and the father of his son’s girlfriend, Stephen Zarsky. All three have pleaded not guilty to the charges against them.

The SEC complaint says that in June 2017, Rep. Collins passed on non-public information about Innate Immunotherapeutics’ unexpectedly negative drug-trial results to his son. The case says that Cameron Collins sold nearly 1.4 million shares based on non-public information.

The Collins’s next father-son fishing trip will most likely be postponed.

 

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

7 hours ago

Interesting. Would be good to know the details of the StrategyOne deal....

4 days 12 hours ago

It’s astonishing to see the FAAA now pushing for more advisers by courting "career changers" and international recruits,...

3 weeks 2 days ago

Insignia Financial has made four appointments, including three who have joined from TAL, to lead strategy and innovation in its retirement solutions for the MLC brand....

2 weeks 4 days ago

A former Brisbane financial adviser has been charged with 26 counts of dishonest conduct regarding a failure to disclose he would receive substantial commission payments ...

3 days 10 hours ago

Pinnacle Investment Management has announced it will acquire strategic interests in two international fund managers for $142 million....

2 days 13 hours ago